Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials

Citation

(2007), "Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials", Clinical Governance: An International Journal, Vol. 12 No. 1. https://doi.org/10.1108/cgij.2007.24812aae.004

Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials

Summaries of abstracts from DARE (Database of Abstracts of Reviews of Effects)

About DARESystematic reviews provide reliable information about what is known and not known about the effects of interventions. But just as with individual studies, systematic reviews can be hard to find, may have methodological flaws and can be difficult to interpret. DARE (Database of Abstracts of Reviews of Effects) provides the solution by systematically identifying and quality assessing reviews from around the world. For each included review an abstract is written that describes the review, including the methods, results and conclusions, together with a critical commentary on the overall quality of the review. DARE contains over 4,000 abstracts of systematic reviews that have been quality-assessed and critically appraised on a broad range of health and social care related topics. The database also includes abstracts of all Cochrane reviews and protocols The database is produced by the Centre for Reviews and Dissemination (CRD), and is publicly available free of charge via the web. The web interface was redesigned and re-launched in September 2006 and now provides users with enhanced search facilities and a clearer layout. DARE on the web is updated every month and contains details of abstracts in the process of being written. The database can now be accessed at www.crd.york.ac.uk

DARE summaries

Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials

J. Costa, M. Borges, C. David, A. Vaz CarneiroBMJ2006Vol. 3321115-1124

This review aimed to determine the efficacy of lipid-lowering drug treatment in patients with and without diabetes mellitus, for primary and secondary prevention. The authors concluded that lipid-lowering treatment, especially statins, reduces cardiovascular risk in diabetic and non-diabetic patients in both primary and secondary prevention. This was a reasonably well-conducted review and the authors’ conclusion is likely to be reliable.